Nuwellis expands commercial footprint with new South Texas territory

Nuwellis (NUWE) announced the creation of a dedicated South Texas commercial territory as part of its ongoing effort to strengthen field engagement in key U.S. hospital markets. By establishing a focused territory, the company aims to provide more direct clinical support to physicians and care teams evaluating advanced fluid management strategies, including Aquadex therapy. “Expanding our presence in strategic hospital markets enables closer collaborations with clinicians as they evaluate and implement ultrafiltration therapy,” said John Erb, CEO of Nuwellis. The addition of the South Texas territory reflects Nuwellis’ continued focus on strengthening its commercial organization and supporting hospitals treating patients with complex cardiorenal conditions.